ジェダイトメディスン

Jadeite Medicines Inc. was established for Japanese patients with its mission of developing and commercializing novel innovative medicines developed globally.

Jadeite Medicines Inc. aims to become the best partner for innovative companies around the world and to meet the unmet medical needs in Japan.

On October 12, 2021, Jadeite Medicines Inc. and Albireo Pharma, Inc. announced a development agreement for odevixibat in Japan. For more information, please refer to the press release.